112 related articles for article (PubMed ID: 7861551)
1. Inhibitory effect of dexamethasone and progesterone in vitro on proliferation of human renal cell carcinomas and effects on expression of interleukin-6 or interleukin-6 receptor.
Takenawa J; Kaneko Y; Okumura K; Yoshida O; Nakayama H; Fujita J
J Urol; 1995 Mar; 153(3 Pt 1):858-62. PubMed ID: 7861551
[TBL] [Abstract][Full Text] [Related]
2. [Studies on the interaction between interleukin-6 and human renal cell carcinoma cell line GRC-1].
Xi Z; Yu L; Guo Y
Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):308-11. PubMed ID: 11798778
[TBL] [Abstract][Full Text] [Related]
3. The expression of interleukin-6 in the pregnant rat corpus luteum and its regulation by progesterone and glucocorticoid.
Telleria CM; Ou J; Sugino N; Ferguson S; Gibori G
Endocrinology; 1998 Aug; 139(8):3597-605. PubMed ID: 9681513
[TBL] [Abstract][Full Text] [Related]
4. The expression of interleukin-6 (IL-6), IL-6 receptor, and gp130-kilodalton glycoprotein in the rat decidua and a decidual cell line: regulation by 17beta-estradiol and prolactin.
Deb S; Tessier C; Prigent-Tessier A; Barkai U; Ferguson-Gottschall S; Srivastava RK; Faliszek J; Gibori G
Endocrinology; 1999 Oct; 140(10):4442-50. PubMed ID: 10499497
[TBL] [Abstract][Full Text] [Related]
5. [Anti-interleukin-6 (IL-6) therapy of IL-6-producing renal cell carcinoma].
Fujita J; Takenawa J; Kaneko Y; Okumura K; Yoshida O
Hinyokika Kiyo; 1992 Nov; 38(11):1333-6. PubMed ID: 1485590
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines.
Shiao RT; McLeskey SB; Khera SY; Wolfson A; Freter CE
Leuk Lymphoma; 1996 Apr; 21(3-4):293-303. PubMed ID: 8726410
[TBL] [Abstract][Full Text] [Related]
7. IL-6 antisense-mediated growth inhibition of a choriocarcinoma cell line: an intracellular autocrine growth mechanism.
Kong B; Isozaki T; Sasaki S
Gynecol Oncol; 1996 Oct; 63(1):78-84. PubMed ID: 8898173
[TBL] [Abstract][Full Text] [Related]
8. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
Obiri NI; Hillman GG; Haas GP; Sud S; Puri RK
J Clin Invest; 1993 Jan; 91(1):88-93. PubMed ID: 8423237
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of interleukin-6 in primary human renal cell carcinomas.
Takenawa J; Kaneko Y; Fukumoto M; Fukatsu A; Hirano T; Fukuyama H; Nakayama H; Fujita J; Yoshida O
J Natl Cancer Inst; 1991 Nov; 83(22):1668-72. PubMed ID: 1749019
[TBL] [Abstract][Full Text] [Related]
10. Expression and production of interleukin 10 in human myeloma cell lines.
Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
[TBL] [Abstract][Full Text] [Related]
11. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
Ganapathi MK; Weizer AK; Borsellino S; Bukowski RM; Ganapathi R; Rice T; Casey G; Kawamura K
Cell Growth Differ; 1996 Jul; 7(7):923-9. PubMed ID: 8809410
[TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin-6 receptor (IL-6R) and gp130 mRNA in PC12 cells and sympathetic neurons: modulation by tumor necrosis factor alpha (TNF-alpha).
März P; Gadient RA; Otten U
Brain Res; 1996 Jan; 706(1):71-9. PubMed ID: 8720493
[TBL] [Abstract][Full Text] [Related]
13. LIF, but not IL-6, regulates osteoprogenitor differentiation in rat calvaria cell cultures: modulation by dexamethasone.
Malaval L; Gupta AK; Liu F; Delmas PD; Aubin JE
J Bone Miner Res; 1998 Feb; 13(2):175-84. PubMed ID: 9495510
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro.
Okamoto M; Hattori K; Oyasu R
Int J Cancer; 1997 Jul; 72(1):149-54. PubMed ID: 9212236
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-11 receptor expression in primary ovarian carcinomas.
Campbell CL; Guardiani R; Ollari C; Nelson BE; Quesenberry PJ; Savarese TM
Gynecol Oncol; 2001 Feb; 80(2):121-7. PubMed ID: 11161848
[TBL] [Abstract][Full Text] [Related]
16. IL-6 as an intracrine growth factor for renal carcinoma cell lines.
Alberti L; Thomachot MC; Bachelot T; Menetrier-Caux C; Puisieux I; Blay JY
Int J Cancer; 2004 Sep; 111(5):653-61. PubMed ID: 15252833
[TBL] [Abstract][Full Text] [Related]
17. Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130).
Geisterfer M; Richards CD; Gauldie J
Cytokine; 1995 Aug; 7(6):503-9. PubMed ID: 8580365
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro.
Okamoto M; Lee C; Oyasu R
Cancer Res; 1997 Jan; 57(1):141-6. PubMed ID: 8988055
[TBL] [Abstract][Full Text] [Related]
19. Changes in IL-6 receptor subunit mRNA expression in primary mouse hepatocyte cultures and murine and rat hepatoma cell lines.
Rokita H; Pierzchalski P; Stalińska K
Ann N Y Acad Sci; 1995 Jul; 762():465-7. PubMed ID: 7668559
[No Abstract] [Full Text] [Related]
20. Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma.
Karczewska A; Nawrocki S; Breborowicz D; Filas V; Mackiewicz A
Cancer; 2000 May; 88(9):2061-71. PubMed ID: 10813718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
